Taylor C. Greenwald, Chief Financial Officer of IBEX Ltd, filed a Form 4 on November 3, 2026, disclosing the acquisition of 10,000 restricted stock units in a grant dated October 30, 2026.

Key Highlights

  • Reporting person: Taylor C. Greenwald, Chief Financial Officer of IBEX Ltd
  • Transaction: Acquisition of 10,000 restricted stock units (RSUs) in Common Shares, coded "A" (acquired), at a price of $0
  • Transaction date: October 30, 2026
  • Beneficial ownership following transaction: 72,788 Common Shares held directly
  • Vesting schedule: 25% of the RSUs vest annually over four years, commencing September 30, 2027, subject to continuous service on each vesting date
  • Tax withholding: On each vesting date, the issuer will automatically withhold shares to satisfy tax withholding obligations in a non-discretionary transaction

IBEX CFO's RSU Grant: Transaction Details and Vesting Terms

According to the Form 4 filed with the SEC, Taylor C. Greenwald, serving as Chief Financial Officer of IBEX Ltd (NASDAQ:IBEX), was granted 10,000 restricted stock units on October 30, 2026. The filing describes RSUs as representing "a contingent right to receive one share of Issuer's Common Stock for each RSU." The acquisition was recorded at a price of $0, consistent with an equity award rather than an open-market purchase. The transaction code reported is "A," denoting an acquisition.

The filing states that 25% of the granted RSUs shall vest annually over four years, with the first vesting date commencing on September 30, 2027, provided that Greenwald remains in continuous service on each vesting date. Following this grant, the filing reports Greenwald's direct beneficial ownership of IBEX Ltd Common Shares at 72,788 shares. The Form 4 was signed by Lisa Lenstrohm, Attorney-in-Fact, and filed on November 3, 2026.

The filing further notes that, unless otherwise provided, on each vesting date the issuer will automatically withhold shares to satisfy the reporting person's tax withholding obligations in a non-discretionary transaction. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

IBEX Ltd CFO Taylor C. Greenwald disclosed the receipt of a 10,000-RSU grant dated October 30, 2026, with a four-year annual vesting schedule beginning September 30, 2027, resulting in direct beneficial ownership of 72,788 Common Shares.